Publication | Open Access

Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naïve, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial

OncologyHuman Papillomavirus-unrelated RecurrentPathologyHead And Neck CancerCancer TreatmentNeck OncologyMedicineRadiation OncologyMetastatic HeadCancer-associated Virus